1.07 USD
▲+0.03+2.88%
盘后 1.05 +0.48%
2026-08-03
市值
$27.04M
市盈率
—
EPS
-0.38
股息率
—
52 周区间
0.88 – 3.40
成交量
153.44K
Beta
0.54
目标价
—
52W 低 0.8852W 高 3.40
价格走势
公司简介
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ...